Edoxaban Tosilate Hydrate

甲苯磺酸艾多沙班

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameEdoxaban Tosilate Hydrate
Drug Alias Nameedoxabanum依度沙班甲苯磺酸水合物对甲苯磺酸依度沙班Edoxaban tosylate Hydrateedoxaban +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsIschemic StrokeInflammationObesity +[17] 
Global Approved IndicationsVenous ThrombosisVenous ThromboembolismEmbolism +[5] 
Approved Indications in ChinaVenous ThromboembolismPulmonary Embolism
Original Approved Country/TerritoryJapan
Original Approved Date2011/04/22
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[62] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Europe GmbhDaiichi Sankyo IncBerlin-Chemie Ag (Menarini Group) +[5] 
Inactive CompaniesUniversite LavalSoon Chun Hyang UniversityHennepin Healthcare Research Institute +[6] 
Active IndicationsVenous ThrombosisVenous ThromboembolismEmbolism +[7] 
Inactive IndicationsIschemic StrokeInflammationObesity +[10] 

Other Information

ATC CodeB01AF03
Related LinksWikipediaDrugBankKEGG